Examining Genetic Factors That Affect the Severity of 22q11.2 Deletion Syndrome
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
22q11.2 deletion syndrome is a genetic disorder that can cause heart defects, facial abnormalities, and developmental and learning disabilities. The severity of the disorder can vary widely among people. This study will analyze DNA from people with 22q11.2 deletion syndrome to identify genetic variations that may affect the severity of the disorder.
| Condition |
|---|
|
DiGeorge Syndrome 22q11.2 Deletion Syndrome |
| Study Type: | Observational |
| Study Design: | Observational Model: Case-Only Time Perspective: Prospective |
| Official Title: | Genetic Modifiers of 22q11.2 Deletion Syndrome |
Blood and saliva samples
| Estimated Enrollment: | 1000 |
| Study Start Date: | August 2000 |
| Estimated Study Completion Date: | January 2011 |
22q11.2 deletion syndrome is a disorder caused by the deletion of a small piece of chromosome 22. Most people with this disorder are missing a sequence of about 3 million DNA building blocks on chromosome 22 within each cell. This disorder affects many areas of the body. People with 22q11.2 deletion syndrome may have heart defects, immune deficiency, kidney abnormalities, hearing loss, and cleft palate or other facial deformities. Many children experience developmental delays and learning disabilities, and they have an increased risk of developing mental illnesses, including schizophrenia, depression, anxiety, and bipolar disorder. All people with 22q11.2 deletion syndrome are missing the same sequence of DNA, but the severity of this disorder varies widely; some people are diagnosed with multiple health and developmental problems, while others experience very few symptoms. In some people, the symptoms may be so minimal that they are not even aware they have 22q11.2 deletion syndrome. This study will examine genetic material—either from blood or saliva—among people with 22q11.2 deletion syndrome. Participants will attend one study visit and undergo either blood or saliva collection. By analyzing the DNA sequences of participants, the study will aim to identify any genetic variations that may affect the severity of 22q11.2 deletion syndrome.
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
People with 22q11.2 deletion syndrome
Inclusion Criteria:
- Has 22q11 deletion of 3 megabases (Mb)
Exclusion Criteria:
- Has 22q11 deletion smaller than 3 Mb or no deletion
Contacts and Locations| Contact: Bernice E. Morrow, PhD | 718-678-1121 | morrow@aecom.yu.edu |
| United States, New York | |
| Albert Einstein College of Medicine | Recruiting |
| New York, New York, United States, 10461 | |
| Principal Investigator: Bernice E. Morrow, PhD | |
| United States, Pennsylvania | |
| Children's Hospital of Philadelphia | Recruiting |
| Philadelphia, Pennsylvania, United States, 19139 | |
| Contact: Beverly S. Emanuel, PhD 215-590-3856 beverly@mail.med.upenn.edu | |
| Principal Investigator: | Bernice E. Morrow, PhD | Albert Einstein College of Medicine, New York |
More Information
No publications provided
| Responsible Party: | Bernice Morrow, Albert Einstein College of Medicine |
| ClinicalTrials.gov Identifier: | NCT00556530 History of Changes |
| Other Study ID Numbers: | 1390, R01 HL084410-01A1 |
| Study First Received: | November 8, 2007 |
| Last Updated: | August 7, 2009 |
| Health Authority: | United States: Federal Government |
Keywords provided by National Heart, Lung, and Blood Institute (NHLBI):
|
Congenital Heart Defects Single Nucleotide Polymorphisms Copy Number Variations Whole Genome Association Study |
Additional relevant MeSH terms:
|
DiGeorge Syndrome 22q11 Deletion Syndrome Craniofacial Abnormalities Musculoskeletal Abnormalities Musculoskeletal Diseases Heart Defects, Congenital Cardiovascular Abnormalities Cardiovascular Diseases Heart Diseases |
Lymphatic Abnormalities Lymphatic Diseases Abnormalities, Multiple Congenital Abnormalities Chromosome Disorders Genetic Diseases, Inborn Hypoparathyroidism Parathyroid Diseases Endocrine System Diseases |
ClinicalTrials.gov processed this record on May 19, 2013